NYC-Based Media Quality Measurement Company Raises $1.4M Seed Funding

An NYC-based company specializing in attention-based media quality measurement raised $1.4M in Seed funding, led by AperiamVentures. The funds will enhance product capabilities and support global team growth. Adelaide, led by CEO Marc Guldimann, offers a platform to improve advertising transparency and optimize campaign performance for large brands.

Borealis Raises $150M in Series A Funding for RNA Medicines

Vancouver-based Borealis secured $150M in Series A funding, led by Versant Ventures and Novartis AG. The funds will enhance their RNA medicine development. Novartis also gains an option to acquire two future programs, potentially earning Borealis up to $750M through clinical and regulatory milestones.

Amount Raises $30M to Enhance AI Capabilities for Credit Unions

Chicago-based SaaS platform Amount secured $30M in equity funding, led by Curql with participation from Goldman Sachs and others. The funds will bolster its technology, focusing on AI and machine learning to support credit unions. Amount helps financial institutions optimize consumer and SMB origination through its integrated platform.

Rhinestone Raises $5M to Enhance Smart Account Infrastructure

Rhinestone, a startup offering tools for developers to enhance smart account features, raised $5M in seed funding led by 1kx, with support from CoinFund, Circle Ventures, and others. The funds will be used to expand operations and its smart account infrastructure, enabling developers to create customizable onchain products.

Halda Therapeutics Raises $126M to Advance Cancer Therapies

New Haven-based biotech firm Halda Therapeutics secured $126M in Series B extension funding, totaling $202M to date. The funds, raised with participation from leading investors including Deep Track Capital and RA Capital Management, will support the development of Halda’s novel cancer therapies, RIPTACTM therapeutics.